4.5 Article

Non coding extremities of the seven influenza virus type C vRNA segments: effect on transcription and replication by the type C and type A polymerase complexes

Journal

VIROLOGY JOURNAL
Volume 5, Issue -, Pages -

Publisher

BMC
DOI: 10.1186/1743-422X-5-132

Keywords

-

Categories

Ask authors/readers for more resources

Background: The transcription/replication of the influenza viruses implicate the terminal nucleotide sequences of viral RNA, which comprise sequences at the extremities conserved among the genomic segments as well as variable 3' and 5' non-coding (NC) regions. The plasmid-based system for the in vivo reconstitution of functional ribonucleoproteins, upon expression of viral-like RNAs together with the nucleoprotein and polymerase proteins has been widely used to analyze transcription/replication of influenza viruses. It was thus shown that the type A polymerase could transcribe and replicate type A, B, or C vRNA templates whereas neither type B nor type C polymerases were able to transcribe and replicate type A templates efficiently. Here we studied the importance of the NC regions from the seven segments of type C influenza virus for efficient transcription/replication by the type A and C polymerases. Results: The NC sequences of the seven genomic segments of the type C influenza virus C/Johannesburg/I/66 strain were found to be more variable in length than those of the type A and B viruses. The levels of transcription/replication of viral-like vRNAs harboring the NC sequences of the respective type C virus segments flanking the CAT reporter gene were comparable in the presence of either type C or type A polymerase complexes except for the NS and PB2-like vRNAs. For the NS-like vRNA, the transcription/replication level was higher after introduction of a U residue at position 6 in the 5' NC region as for all other segments. For the PB2-like vRNA the CAT expression level was particularly reduced with the type C polymerase. Analysis of mutants of the 5' NC sequence in the PB2-like vRNA, the shortest 5' NC sequence among the seven segments, showed that additional sequences within the PB2 ORF were essential for the efficiency of transcription but not replication by the type C polymerase complex. Conclusion: In the context of a PB2-like reporter vRNA template, the sequence upstream the polyU stretch plays a role in the transcription/replication process by the type C polymerase complex.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Infectious Diseases

Persistence of IgG response to SARS-CoV-2

Els Duysburgh, Laure Mortgat, Cyril Barbezange, Katelijne Dierick, Natalie Fischer, Leo Heyndrickx, Veronik Hutse, Isabelle Thomas, Steven Van Gucht, Bea Vuylsteke, Kevin K. Arien, Isabelle Desombere

LANCET INFECTIOUS DISEASES (2021)

Article Infectious Diseases

Spotlight influenza: Extending influenza surveillance to detect non-influenza respiratory viruses of public health relevance: analysis of surveillance data, Belgium, 2015 to 2019

Lorenzo Subissi, Nathalie Bossuyt, Marijke Reynders, Michele Gerard, Nicolas Dauby, Patrick Lacor, Siel Daelemans, Benedicte Lissoir, Xavier Holemans, Koen Magerman, Door Jouck, Marc Bourgeois, Benedicte Delaere, Sophie Quolin, Steven Van Gucht, Isabelle Thomas, Cyril Barbezange

Summary: The study in Belgium found that non-influenza respiratory viruses (NIRV) contributed significantly to severe acute respiratory infections (SARI), with a high positivity rate among children, particularly those under 15 years old. The incidence rates of NIRV-associated SARI were higher than influenza, especially in children under 5 years old. Co-infections with multiple NIRV and other respiratory viruses further contributed to the burden of SARI, highlighting the importance of early testing for NIRV in clinical management, especially for young children.

EUROSURVEILLANCE (2021)

Article Infectious Diseases

SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data

Dung Nguyen, Peter Simmonds, Maurice Steenhuis, Elise Wouters, Daniel Desmecht, Mutien Garigliany, Marta Romano, Cyril Barbezange, Piet Maes, Bram Van Holm, Joaquin Mendoza, Salvador Oyonarte, Anders Fomsgaard, Ria Lassauniere, Eva Zusinaite, Katarina Resman Rus, Tatjana Avsic-Zupanc, Johan H. J. Reimerink, Fiona Brouwer, Marieke Hoogerwerf, Chantal B. E. M. Reusken, Gunnveig Grodeland, Sophie Le Cam, Pierre Gallian, Abdennour Amroun, Nadege Brisbarre, Christophe Martinaud, Isabelle Leparc Goffart, Hubert Schrezenmeier, Hendrik B. Feys, C. Ellen van der Schoot, Heli Harvala

Summary: The research compared the performance of SARS-CoV-2 neutralising antibody testing among 12 European laboratories involved in convalescent plasma trials. It was found that there were significant differences in titres between laboratories during blind-testing, but calibration of titres reduced this variability. Harmonisation of neutralising antibody quantification is a crucial step towards determining protective and therapeutic levels of neutralising antibodies.

EUROSURVEILLANCE (2021)

Letter Medicine, Research & Experimental

SARS-CoV-2 Omicron emergence urges for reinforced One-Health surveillance

Xavier Montagutelli, Sylvie van der Werf, Felix A. Rey, Etienne Simon-Loriere

Summary: SARS-CoV-2 Omicron variant has substitutions in the receptor binding domain of the spike protein, indicating its potential to infect rodents. The existence of wild animal reservoirs could facilitate the emergence of new variants with the risk of transmission to humans, and therefore should be closely monitored.

EMBO MOLECULAR MEDICINE (2022)

Article Biochemistry & Molecular Biology

A virus-derived microRNA targets immune response genes during SARS-CoV-2 infection

Meetali Singh, Maxime Chazal, Piergiuseppe Quarato, Loan Bourdon, Christophe Malabat, Thomas Vallet, Marco Vignuzzi, Sylvie van der Werf, Sylvie Behillil, Flora Donati, Nathalie Sauvonnet, Giulia Nigro, Maryline Bourgine, Nolwenn Jouvenet, Germano Cecere

Summary: A virus-derived miRNA produced during SARS-CoV-2 infection can target interferon-stimulated genes and suppress their expression, potentially aiding the virus in evading the host immune response. Detection of these viral miRNA isoforms in COVID-19 patients' samples suggests a mechanism by which the virus hijacks the host miRNA machinery.

EMBO REPORTS (2022)

Article Biochemistry & Molecular Biology

sgDI-tector: defective interfering viral genome bioinformatics for detection of coronavirus subgenomic RNAs

Andrea Di Gioacchino, Rachel Legendre, Yannis Rahou, Valerie Najburg, Pierre Charneau, Benjamin D. Greenbaum, Frederic Tangy, Sylvie van der Werf, Simona Cocco, Anastassia Komarova

Summary: It is crucial to study the production of sgRNA in the vast amount of NGS data of SARS-CoV-2, and a user-friendly bioinformatic tool called sgDI-tector is introduced to identify and quantify these sgRNAs. Researchers successfully detected the nested set of sgRNAs in SARS-CoV-2 using this tool, and compared their production level with other types of viral RNA products.
Article Immunology

Functional Analysis of Human and Feline Coronavirus Cross-Reactive Antibodies Directed Against the SARS-CoV-2 Fusion Peptide

Nathalie Vanderheijden, Annelies Stevaert, Jiexiong Xie, Xiaolei Ren, Cyril Barbezange, Sam Noppen, Isabelle Desombere, Bruno Verhasselt, Peter Geldhof, Nick Vereecke, Veerle Stroobants, Dayoung Oh, Merijn Vanhee, Lieve M. J. Naesens, Hans J. Nauwynck

Summary: Broadly protective therapeutic antibodies are urgently needed to combat SARS-CoV-2 variants. Researchers have found that antibodies formed during coronavirus infection can target multiple coronaviruses. These antibodies can bind to both alpha- and betacoronaviruses, but their neutralizing activity against SARS-CoV-2 is weak. However, they may still play a role in influencing the severity of coronavirus infection and disease through Fc-mediated effector functions.

FRONTIERS IN IMMUNOLOGY (2022)

Article Biology

Is the Alpha Variant of SARS-CoV-2 Associated with a Higher Viral Load than the Historical Strain in Saliva Samples in Patients with Mild to Moderate Symptoms?

Camille Bonnet, Shirley Masse, Hayat Benamar, Ana-Maria Vilcu, Morgane Swital, Thomas Hanslik, Sylvie van der Werf, Xavier Duval, Fabrice Carrat, Alessandra Falchi, Thierry Blanchon

Summary: The study compared the evolution of viral load between patients infected with the Alpha variant and those infected with historical SARS-CoV-2 strains, finding no significant difference in viral load evolution in saliva samples when controlling for the time interval between symptom onset and sampling.

LIFE-BASEL (2022)

Article Virology

Prevalence of Anti-SARS-CoV-2 Antibodies and Potential Determinants among the Belgian Adult Population: Baseline Results of a Prospective Cohort Study

Victoria Leclercq, Nayema van den Houte, Lydia Gisle, Inge Roukaerts, Cyril Barbezange, Isabelle Desombere, Els Duysburgh, Johan Van der Heyden

Summary: This study examined the prevalence of anti-SARS-CoV-2 antibodies and the factors associated with their presence in the Belgian adult population. The results showed a significant increase in antibody prevalence after the onset of the vaccination campaign, while the prevalence remained stable among the unvaccinated individuals.

VIRUSES-BASEL (2022)

Article Multidisciplinary Sciences

C910 chemical compound inhibits the traffiking of several bacterial AB toxins with cross-protection against influenza virus

Yu Wu, Nassim Mahtal, Elea Paillares, Lea Swistak, Sara Sagadiev, Mridu Acharya, Caroline Demeret, Sylvie Van der Werf, Florence Guivel-Benhassine, Olivier Schwartz, Serena Petracchini, Amel Mettouchi, Lucie Caramelle, Pierre Couvineau, Robert Thai, Peggy Barbe, Mathilde Keck, Priscille Brodin, Arnaud Machelart, Valentin Sencio, Francois Trottein, Martin Sachse, Gaetan Chicanne, Bernard Payrastre, Florian Ville, Victor Kreis, Michel-Robert Popoff, Ludger Johannes, Jean-Christophe Cintrat, Julien Barbier, Daniel Gillet, Emmanuel Lemichez

Summary: The compound C910 has been identified to disrupt toxin transport pathways, protecting cells against various bacterial toxins and reducing influenza and SARS-CoV-2 viral infections.

ISCIENCE (2022)

Article Infectious Diseases

Efficacy and safety of camostat mesylate in early COVID-19 disease in an ambulatory setting: a randomized placebo-controlled phase II trial

Els Tobback, Sophie Degroote, Sabine Buysse, Liesbeth Delesie, Lucas Van Dooren, Sophie Vanherrewege, Cyril Barbezange, Veronik Hutse, Marta Romano, Isabelle Thomas, Elizaveta Padalko, Steven Callens, Marie-Angelique De Scheerder

Summary: This study assessed the efficacy and safety of 300 mg camostat mesylate three times daily in a fasted state to treat early phase COVID-19. The results showed that camostat mesylate was not found to be effective as an antiviral drug against SARS-CoV-2.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2022)

Article Multidisciplinary Sciences

High-throughput droplet-based analysis of influenza A virus genetic reassortment by single-virus RNA sequencing

Kuang-Yu Chen, Jayaprakash Karuppusamy, Mary B. O'Neill, Vaitea Opuu, Mathieu Bahin, Sophie Foulon, Pablo Ibanez, Lluis Quintana-Murci, Tatsuhiko Ozawa, Sylvie van der Werf, Philippe Nghe, Nadia Naffakh, Andrew Griffiths, Catherine Isel

Summary: Using a high-throughput single-cell droplet microfluidic system, researchers have quantitatively studied influenza viruses and found that genetic reassortment is non-random. They accurately predicted the fraction of pairwise segments and full genotypes and discovered that a large proportion of reassortant genotypes can emerge upon coinfection and be detected at different frequencies, highlighting the importance of systematic and exhaustive monitoring of the reassortment potential of influenza viruses.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2023)

Article Respiratory System

Early high antibody titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma

Timothy Devos, Quentin Van Thillo, Veerle Compernolle, Tome Najdovski, Marta Romano, Nicolas Dauby, Laurent Jadot, Mathias Leys, Evelyne Maillart, Sarah Loof, Lucie Seyler, Martial Moonen, Michel Moutschen, Niels Van Regenmortel, Kevin K. Arien, Cyril Barbezange, Albrecht Betrains, Mutien Garigliany, Matthias M. Engelen, Iwein Gyselinck, Piet Maes, Alexander Schauwvlieghe, Laurens Liesenborghs, Ann Belmans, Peter Verhamme, Geert Meyfroidt

Summary: Transfusion of 4 units of convalescent plasma with high neutralising antibody titres early in hospitalised COVID-19 patients did not result in a significant improvement of clinical status or reduced mortality.

EUROPEAN RESPIRATORY JOURNAL (2022)

Article Public, Environmental & Occupational Health

The prior infection with SARS-CoV-2 study (PICOV) in nursing home residents and staff-study protocol description and presentation of preliminary findings on symptoms.

Maria E. Goossens, Kristof Y. Neven, Pieter Pannus, Cyril Barbezange, Isabelle Thomas, Steven Van Gucht, Katelijne Dierick, Marie-Noelle Schmickler, Mathieu Verbrugghe, Nele Van Loon, Kevin K. Arien, Arnaud Marchant, Stanislas Goriely, Isabelle Desombere

Summary: The study aims to compare COVID-19 disease development and symptomatology between geriatric and younger population, showing that older individuals tend to have more symptoms before and after infection, and there are differences in the rate of asymptomatic cases between residents and staff members post-infection.

ARCHIVES OF PUBLIC HEALTH (2021)

Article Biochemistry & Molecular Biology

sgDI-tector: defective interfering viral genome bioinformatics for detection of coronavirus subgenomic RNAs

Andrea Di Gioacchino, Rachel Legendre, Yannis Rahou, Valerie Najburg, Pierre Charneau, Benjamin D. Greenbaum, Frederic Tangy, Sylvie van der Werf, Simona Cocco, Anastassia V. Komarova

Summary: Researchers have developed a user-friendly bioinformatic tool sgDI-tector to detect and quantify sgRNA production in SARS-CoV-2 NGS data, providing an effective method for studying subgenomic RNAs of coronaviruses.
No Data Available